(Total Views: 296)
Posted On: 08/14/2025 5:06:55 PM
Post# of 87418
IR-Med 10-K today; Going Concern
The Company is starting the preparations of the commercial launch of its first device, the PressureSafe™, and does not expect to generate significant revenue until such time as the Company will start the commercialization of the PressureSafe™ and shall complete the design and development of its other product candidates. During the six months ended June 30, 2025, the Company incurred losses of $1,474 thousand and had a negative cash flow from operating activities of $181 thousand. The accumulated deficit as of June 30, 2025 is $18,212 thousand.
https://www.otcmarkets.com/filing/html?id=186...a4Zfvl8h3h
The Company is starting the preparations of the commercial launch of its first device, the PressureSafe™, and does not expect to generate significant revenue until such time as the Company will start the commercialization of the PressureSafe™ and shall complete the design and development of its other product candidates. During the six months ended June 30, 2025, the Company incurred losses of $1,474 thousand and had a negative cash flow from operating activities of $181 thousand. The accumulated deficit as of June 30, 2025 is $18,212 thousand.
https://www.otcmarkets.com/filing/html?id=186...a4Zfvl8h3h
(3)
(0)
